Patent · US Expired

Method of using HRG2-.alpha. to stimulate P185.sup.HeR2

US5856110A · kind A · utility

40Cited by
10References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 12, 1995
Grant dateJan 5, 1999
Priority date
Expiry dateMay 12, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel 2 polypeptides with binding affinity for the p185.sup.HER2 receptor, designated heregulin 2-.alpha. and heregulin 2-.beta., have been identified and purified from human tissue. The cDNA encoding the novel heregulin 2-.alpha. has been isolated from human tissue and sequenced. Provided herein is nucleic acid sequence of the heregulin 2-.alpha. useful in the production of heregulin 2-.alpha. by recombinant means. Further provided an amino acid sequence of heregulin 2-.alpha. and heregulin 2-.beta.. Heregulins and their antibodies are useful as therapeutic agents and in diagnostic methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.